By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CoLucid Pharmaceuticals, Inc. 

902 North Capitol Avenue
Suite 302
Indianapolis  Indiana  46204  U.S.A.
Phone: 317-684-6703 Fax:



Company News
CoLucid Pharma (CLCD) To Present Corporate Overview At The Stifel 2015 Healthcare Conference 11/12/2015 8:29:06 AM
CoLucid Pharma (CLCD) Announces Third Quarter 2015 Results And Corporate Highlights 11/10/2015 8:17:25 AM
CoLucid Pharma (CLCD) Announces Election Of Mark Corrigan, M.D., To Board Of Directors 10/27/2015 7:44:50 AM
CoLucid Pharma (CLCD) Announces Initiation Of Phase III Long-Term, Open-Label Trial Of Lasmiditan In Migraine 10/8/2015 7:17:45 AM
CoLucid Pharma To Present At Two Investor Conferences In September 9/3/2015 7:28:49 AM
CoLucid Pharma Announces Second Quarter 2015 Results And Corporate Highlights 8/13/2015 9:57:04 AM
CoLucid Pharma Announces Appointment Of Marvin L. White To Board Of Directors 7/13/2015 7:08:22 AM
CoLucid Pharma Announces Pricing Of IPO 5/6/2015 7:25:08 AM
CoLucid Pharma Announces Initiation Of First Phase 3 Pivotal Trial Of Lasmiditan In Migraine 4/28/2015 7:29:01 AM
After Exiting RTP, CoLucid Pharma Files with SEC for $86M IPO 3/31/2015 7:59:37 AM